Transactions
8
Insider / NATIONAL HEALTH INVESTORS INC
MCCABE ROBERT A JR
Director at NATIONAL HEALTH INVESTORS INC
- Ticker
- NHI
- First filing on record
- January 16, 2026
- Latest trade on record
- June 15, 2026
- SEC filings
- EDGAR ↗
MCCABE ROBERT A JR, Director at NATIONAL HEALTH INVESTORS INC, has disclosed 8 transactions in NHI since January 16, 2026: 1 purchase (1 open-market buy) and 2 sales, worth about $5.0M at the reported prices. The latest was filed June 15, 2026, 0 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
1
Sales
2
Avg. disclosure lag
2.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months MCCABE ROBERT A JR made 1 purchase worth $64K and 2 sales worth $2.5M, plus 5 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
MCCABE ROBERT A JR has traded 1 stock on record; the largest by dollars is NHI.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 4 | 70,000 | $2.5M |
| F | Shares withheld for tax | 2 | 30,016 | $2.5M |
| A | Grant or award | 1 | 1,268 | — |
| P | Open-market purchase | 1 | 890 | $64K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 8 | 1 · $64K | 2 · $2.5M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| NHI | Buy P | June 15, 2026 | June 15, 2026 | 0d | 890 | $72 | $64K | Form 4 ↗ | ||
| NHI | Other A | March 3, 2026 | March 5, 2026 | 2d | 1,268 | — | — | Form 4 ↗ | ||
| NHI | Option / conversion M | February 12, 2026 | February 17, 2026 | 5d | 10,000 | — | — | latederivative | Form 4 ↗ | |
| NHI | Sell F | February 12, 2026 | February 17, 2026 | 5d | 8,180 | $90 | $733K | late | Form 4 ↗ | |
| NHI | Option / conversion M | February 12, 2026 | February 17, 2026 | 5d | 10,000 | $73 | $733K | late | Form 4 ↗ | |
| NHI | Option / conversion M | January 14, 2026 | January 16, 2026 | 2d | 25,000 | — | — | derivative | Form 4 ↗ | |
| NHI | Sell F | January 14, 2026 | January 16, 2026 | 2d | 21,836 | $79 | $1.7M | Form 4 ↗ | ||
| NHI | Option / conversion M | January 14, 2026 | January 16, 2026 | 2d | 25,000 | $69 | $1.7M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 15, 2026 | Form 4 | 0000877860-26-000159 | 1 | published | EDGAR ↗ |
| March 5, 2026 | Form 4 | 0000877860-26-000074 | 1 | published | EDGAR ↗ |
| February 17, 2026 | Form 4 | 0000877860-26-000022 | 3 | published | EDGAR ↗ |
| January 16, 2026 | Form 4 | 0000877860-26-000003 | 3 | published | EDGAR ↗ |
Other insiders at NATIONAL HEALTH INVESTORS INC
- Mendelsohn D. Eric CEO and President 22 rows
- Travis David L SVP/Chief Accounting Officer 21 rows
- Spaid John L CFO/EVP Finance 17 rows
- PASCOE KEVIN CARLTON Chief Investment Officer 12 rows
- SWAFFORD CHARLOTTE A Director 11 rows
- Jobe James R Director 8 rows
- Gaines Kristin Sallee SVP/Chief Transaction Officer 7 rows
- ADAMS ROBERT G Director 5 rows
- COLDEN TRACY M J Director 4 rows
- Todd Candice W Director 4 rows
Everyone on file, with contracts and lobbying under the company's name: NATIONAL HEALTH INVESTORS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 8 | January 16, 2026 | June 15, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.